Unknown

Dataset Information

0

Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.


ABSTRACT: PURPOSE:The natural history and prognosis of appendiceal adenocarcinomas differ from those of adenocarcinomas arising in other large bowel sites. We aimed to compare the molecular profiles exhibited by appendiceal adenocarcinomas and colorectal cancers, or between the histopathologic subtypes of appendiceal adenocarcinoma. EXPERIMENTAL DESIGN:A total of 183 samples from appendiceal adenocarcinoma [46 adenocarcinoma, not otherwise specified (NOS), 66 pseudomyxoma peritonei (PMP), 44 mucinous adenocarcinoma (MU), and 27 signet ring cell carcinoma (SR)], 994 from right-sided colorectal cancer (R-CRC), and 1,080 from left-sided CRC (L-CRC) were analyzed by next-generation sequencing (NGS) and IHC markers. Microsatellite instability (MSI) and tumor mutational burden (TMB) were tested by NGS, and programmed death ligand 1 (PD-L1) by IHC. RESULTS:We observed high mutation rates in appendiceal adenocarcinoma samples for KRAS (55%), TP53 (40%), GNAS (31%), SMAD4 (16%), and APC (10%). Appendiceal adenocarcinoma exhibited higher mutation rates in KRAS and GNAS, and lower mutation rates in TP53, APC, and PIK3CA (6%) than colorectal cancers. PMP exhibited much higher mutation rates in KRAS (74%) and GNAS (63%), and much lower mutation rates in TP53 (23%), APC (2%), and PIK3CA (2%) than NOS. Alterations associated with immune checkpoint inhibitor response (MSI-high, TMB-high, PD-L1 expression) showed similar frequency in appendiceal adenocarcinoma compared with L-CRC, but not R-CRC, and those of NOS were higher than other subtypes of appendiceal adenocarcinoma and L-CRC. CONCLUSIONS:Molecular profiling of appendiceal adenocarcinoma revealed different molecular characteristics than noted in R-CRC and L-CRC, and molecular heterogeneity among the histopathologic subtypes of appendiceal adenocarcinoma. Our findings may be critical to developing an individualized approach to appendiceal adenocarcinoma treatment.

SUBMITTER: Tokunaga R 

PROVIDER: S-EPMC6886223 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.

Tokunaga Ryuma R   Xiu Joanne J   Johnston Curtis C   Goldberg Richard M RM   Philip Philip A PA   Seeber Andreas A   Naseem Madiha M   Lo Jae Ho JH   Arai Hiroyuki H   Battaglin Francesca F   Puccini Alberto A   Berger Martin D MD   Soni Shivani S   Zhang Wu W   Hwang Jimmy J JJ   Shields Anthony F AF   Marshall John L JL   Baba Hideo H   Korn W Michael WM   Lenz Heinz-Josef HJ  

Clinical cancer research : an official journal of the American Association for Cancer Research 20190128 10


<h4>Purpose</h4>The natural history and prognosis of appendiceal adenocarcinomas differ from those of adenocarcinomas arising in other large bowel sites. We aimed to compare the molecular profiles exhibited by appendiceal adenocarcinomas and colorectal cancers, or between the histopathologic subtypes of appendiceal adenocarcinoma.<h4>Experimental design</h4>A total of 183 samples from appendiceal adenocarcinoma [46 adenocarcinoma, not otherwise specified (NOS), 66 pseudomyxoma peritonei (PMP), 4  ...[more]

Similar Datasets

| S-EPMC7726112 | biostudies-literature
| S-EPMC5911618 | biostudies-literature
| S-EPMC8765049 | biostudies-literature
| S-EPMC7216442 | biostudies-literature
2021-11-15 | GSE188711 | GEO
| S-EPMC5486063 | biostudies-literature